Together, our study highlighted CAF-secreted CXCL1 as an attractive target to reverse tumor radioresistance and can be used as an independent prognostic factor of ESCC patients treated with chemoradiotherapy. The gene discussed is CXCL1; the disease is esophageal squamous cell carcinoma.